AI Insight
This study uses a computational tool called targPred to identify genes regulated by non-coding genetic variants associated with four immune-mediated diseases: ulcerative colitis, Crohn's disease, primary sclerosing cholangitis, and ankylosing spondylitis. By incorporating evolutionary and comparative genomic data, the researchers identified shared genetic mechanisms across all four diseases, including novel gene clusters related to platelet, vascular, and sterol pathways, as well as disease-specific patterns. The analysis revealed clinically relevant target genes like COG6 that are shared between inflammatory bowel diseases and primary sclerosing cholangitis, which conventional gene mapping methods failed to detect.
Why it matters
This research helps explain how non-coding genetic variants contribute to multiple immune-mediated diseases and reveals shared biological mechanisms that could lead to new therapeutic targets. Understanding these long-range regulatory interactions may enable the development of treatments that address multiple related conditions simultaneously and improve prediction of disease risk and progression.
Understand the Science
⚠️ Preprint – Noch nicht peer-reviewed
Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.
Common variants detected by the genome-wide association studies (GWAS) create a wealth of knowledge on genetic component of individual traits and diseases. Elucidating the molecular mechanism behind the vast majority of these variants that are found to be non-coding remains a largely unsolved task, especially when distal and pleiotropic interactions between regulatory elements where these variants occur and gene promoters are taken into account. Focusing on four diseases with immune-mediated mechanisms namely ulcerative colitis, Crohn’s disease, primary sclerosing cholangitis and ankylosing spondylitis, we demonstrate the utility of the targPred tool, providing prediction of genes targeted by the regulatory variants. We demonstrate that taking into account evolutionary and comparative genomic data, previously unobserved mechanistic trends (the platelet, vascular and sterol clusters) can be detected in terms of implicated genes targeted by the regulatory elements containing common variants, shared between all four diseases, as well as specific trends for subsets of diseases, e.g. two IBD phenotypes. We also elucidate a clinically-relevant target COG6 shared between IBD and PSC, as well as a whole range of other target genes missed by the conventional SNP-to-gene assignments methods.